IRulya Therapeutics Inc.
IRLA· Nasdaq
IRLAIRulya Therapeutics Inc.
Filed Nov 12, 2019 · 10-Q · 43 days after period end · 0001564590-19-042988
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Net Income | -$9.86M | -$2.52M |
| EPS Diluted | -$0.37 | -$0.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IRulya Therapeutics Inc. · CIK 1662774 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 12, 2019 · 43 d after period end
